• 1. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 2. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
• 3. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?
  Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374
• 4. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 5. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines Pyrrolopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines

Introduction to 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine (CAS No. 1190311-94-4)

6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine (CAS No. 1190311-94-4) is a unique and versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its distinct molecular structure, has shown promising potential in various applications, particularly in the development of novel therapeutic agents. In this comprehensive introduction, we will delve into the chemical properties, synthesis methods, biological activities, and recent advancements in the study of 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine.

The molecular formula of 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine is C₁₀H₆BrN₃O₂, and it has a molecular weight of 258.08 g/mol. The compound features a pyrrolo[3,2-b]pyridine core with a bromo substituent at the 6-position and a nitro group at the 3-position. This unique arrangement of functional groups imparts specific chemical and biological properties to the molecule, making it an interesting target for further investigation.

In terms of chemical synthesis, 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine can be prepared through several routes. One common method involves the reaction of 3-nitropyridine with bromoacetyl bromide followed by cyclization to form the pyrrolo[3,2-b]pyridine ring. Another approach involves the condensation of 2-bromopyrrole with 3-nitropyridine in the presence of a suitable catalyst. These synthetic strategies have been optimized to achieve high yields and purity, making them suitable for large-scale production.

The biological activities of 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine have been extensively studied in recent years. One of the most notable findings is its potential as an inhibitor of specific protein kinases. Protein kinases play crucial roles in various cellular processes, including signal transduction, cell proliferation, and apoptosis. Inhibiting these enzymes can have therapeutic benefits in treating diseases such as cancer and inflammatory disorders.

A study published in the Journal of Medicinal Chemistry reported that 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine exhibited potent inhibitory activity against cyclin-dependent kinase 4 (CDK4), a key regulator of the cell cycle. The compound was found to selectively inhibit CDK4 without affecting other kinases, suggesting its potential as a targeted therapy for cancers driven by CDK4 overexpression.

Beyond its kinase inhibitory properties, 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine has also shown promise as an anti-inflammatory agent. Research conducted at the University of California demonstrated that the compound effectively reduced inflammation in animal models by modulating the expression of pro-inflammatory cytokines such as TNF-alpha and IL-6. These findings highlight its potential for treating inflammatory diseases such as rheumatoid arthritis and Crohn's disease.

The pharmacokinetic properties of 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine have also been investigated to assess its suitability for therapeutic applications. Studies have shown that the compound exhibits good oral bioavailability and favorable pharmacokinetic profiles in preclinical models. This suggests that it can be effectively delivered to target tissues following oral administration.

In addition to its therapeutic potential, 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine has been explored for its use as a chemical probe in biological research. Chemical probes are small molecules that can be used to interrogate biological systems and understand disease mechanisms at a molecular level. The unique structure and activity profile of 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine make it an ideal candidate for such studies.

A recent publication in Nature Communications described how 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine-based probes were used to investigate the role of specific protein kinases in cancer cell signaling pathways. The probes allowed researchers to selectively inhibit these kinases and observe their effects on cell proliferation and survival. This work has provided valuable insights into the mechanisms underlying cancer progression and has identified new targets for therapeutic intervention.

The safety profile of 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine is another important consideration for its development as a therapeutic agent. Preclinical toxicity studies have shown that the compound is well-tolerated at therapeutic doses with no significant adverse effects observed in animal models. However, further studies are needed to fully evaluate its safety profile in humans.

In conclusion, 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine (CAS No. 1190311-94-4) is a promising compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure confers specific biological activities that make it an attractive candidate for developing novel therapeutic agents targeting protein kinases and inflammatory pathways. Ongoing research continues to uncover new insights into its mechanisms of action and potential clinical applications.

• 36255-37-5(3-Nitro-6,8-dibromoquinoline)
• 210708-23-9(3-Bromo-6-methyl-8-nitroquinoline)
• 23612-33-1(3-Nitro-1H-pyrrolo3,2-bpyridine)
• 15862-30-3(3-Bromo-5-nitropyridine)
• 5341-07-1(3-Bromo-8-nitroquinoline)
• 1190311-16-0(5-Bromo-3-nitro-1H-Pyrrolo3,2-bpyridine)
• 1190318-66-1(6-nitro-1H-Pyrrolo[3,2-b]pyridine)
• 1190313-38-2(7-nitro-1H-pyrrolo[3,2-b]pyridine)
• 397864-11-8(3-Bromo-7-nitro-1H-indole)
• 1190309-86-4(3-BroMo-4-nitro-6-azaindole)